Junbao Liu

476 total citations
19 papers, 334 citations indexed

About

Junbao Liu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Junbao Liu has authored 19 papers receiving a total of 334 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Cancer Research and 4 papers in Oncology. Recurrent topics in Junbao Liu's work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Junbao Liu is often cited by papers focused on Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (3 papers) and Circular RNAs in diseases (3 papers). Junbao Liu collaborates with scholars based in China and United States. Junbao Liu's co-authors include Yubo Hu, Cong Ye, Yu Chen, Jifeng Feng, Jianwei Lu, Weibing Li, Minjia Sheng, Yingjian Wang, Dan Chen and Fangtian Fan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, American Journal of Physiology-Gastrointestinal and Liver Physiology and Frontiers in Pharmacology.

In The Last Decade

Junbao Liu

19 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junbao Liu China 11 219 149 52 41 27 19 334
Yueling Jin China 11 218 1.0× 108 0.7× 36 0.7× 36 0.9× 30 1.1× 21 353
Shufang Liang China 11 189 0.9× 96 0.6× 45 0.9× 44 1.1× 47 1.7× 17 313
Eman Khairy Egypt 12 158 0.7× 82 0.6× 50 1.0× 36 0.9× 25 0.9× 25 340
Yiman Liu China 3 306 1.4× 207 1.4× 37 0.7× 45 1.1× 17 0.6× 6 405
Tong Xu China 9 193 0.9× 107 0.7× 28 0.5× 57 1.4× 27 1.0× 24 338
Małgorzata Guz Poland 13 198 0.9× 145 1.0× 58 1.1× 63 1.5× 21 0.8× 21 346

Countries citing papers authored by Junbao Liu

Since Specialization
Citations

This map shows the geographic impact of Junbao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junbao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junbao Liu more than expected).

Fields of papers citing papers by Junbao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junbao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junbao Liu. The network helps show where Junbao Liu may publish in the future.

Co-authorship network of co-authors of Junbao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Junbao Liu. A scholar is included among the top collaborators of Junbao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junbao Liu. Junbao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Liu, Junbao, et al.. (2025). STEAP3 promotes triple-negative breast cancer growth through the FGFR1-mediated activation of PI3K/AKT/mTOR signaling. iScience. 28(6). 112526–112526. 1 indexed citations
2.
Liu, Junbao, et al.. (2024). Caffeic acid inhibits Staphylococcus aureus‐induced endometritis through regulating AMPKα/mTOR/HIF‐1α signalling pathway. Journal of Cellular and Molecular Medicine. 28(20). e70175–e70175. 6 indexed citations
3.
Liu, Junbao, et al.. (2023). Selenomethionine protects against Escherichia coli-induced endometritis by inhibiting inflammation and necroptosis via regulating the PPAR-γ/NF-κB pathway. Chemico-Biological Interactions. 379. 110532–110532. 11 indexed citations
4.
Liu, Junbao, Yubo Hu, Linlin Li, & Longyun Li. (2021). Hypaconitine confers protection on ketamine-induced neuronal injury in neonatal rat brain via a mechanism involving PI3K/Akt/Bcl-2 pathway. Tropical Journal of Pharmaceutical Research. 18(9). 1839–1844. 1 indexed citations
5.
Yang, Ming, et al.. (2021). miR‑130b regulates PTEN to activate the PI3K/Akt signaling pathway and attenuate oxidative stress‑induced injury in diabetic encephalopathy. International Journal of Molecular Medicine. 48(1). 12 indexed citations
6.
Liu, Junbao, Dan Chen, Tingting Bao, Fangtian Fan, & Yu Chen. (2020). The Anticancer Effects of Atractylenolide III Associate With the Downregulation of Jak3/Stat3-Dependent IDO Expression. Frontiers in Pharmacology. 10. 1505–1505. 24 indexed citations
7.
Hu, Yubo, et al.. (2020). miR-1224-5p inhibits the proliferation and invasion of ovarian cancer via targeting SND1. Human Cell. 33(3). 780–789. 18 indexed citations
8.
Dai, Chunmei, et al.. (2020). <p>Long Noncoding RNA SNHG15 Serves as an Oncogene and Predicts Poor Prognosis in Epithelial Ovarian Cancer [Expression of Concern]</p>. OncoTargets and Therapy. Volume 13. 6747–6748. 3 indexed citations
9.
Liu, Junbao, et al.. (2019). Aurora-A/NF-ĸB Signaling Is Associated With Radio-resistance in Human Lung Adenocarcinoma. Anticancer Research. 39(11). 5991–5998. 20 indexed citations
10.
Zhao, Peng, Suyavaran Arumugam, Muhammad Nadeem Yousaf, et al.. (2019). Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation. American Journal of Physiology-Gastrointestinal and Liver Physiology. 317(4). G387–G397. 35 indexed citations
11.
Ye, Cong, et al.. (2018). UCA1 confers paclitaxel resistance to ovarian cancer through miR-129/ABCB1 axis. Biochemical and Biophysical Research Communications. 501(4). 1034–1040. 74 indexed citations
12.
Liu, Li‐Juan, Yu Chen, & Junbao Liu. (2018). Effect of Cuzhi liquid on learning and memory dysfunction in a mouse model of Alzheimer's disease. Journal of Traditional Chinese Medicine. 38(6). 890–895. 3 indexed citations
13.
Qin, Rui, Lu Cao, Junrong Wang, & Junbao Liu. (2018). Promoter Methylation of Ezrin and its Impact on the Incidence and Prognosis of Cervical Cancer. Cellular Physiology and Biochemistry. 50(1). 277–287. 8 indexed citations
14.
Chen, Yu, Weibing Li, Junbao Liu, Jianwei Lu, & Jifeng Feng. (2017). Autophagy: novel applications of nonsteroidal anti‐inflammatory drugs for primary cancer. Cancer Medicine. 7(2). 471–484. 56 indexed citations
15.
Liu, Junbao, et al.. (2016). Inhibition of microRNA-383 has tumor suppressive effect in human epithelial ovarian cancer through the action on caspase-2 gene. Biomedicine & Pharmacotherapy. 83. 1286–1294. 23 indexed citations
16.
17.
Wang, Yingjian, et al.. (2015). Sequential treatment with betulinic acid followed by 5-fluorouracil shows synergistic cytotoxic activity in ovarian cancer cells.. PubMed. 8(1). 252–9. 18 indexed citations
18.
Cui, Chengxu, Chang Shu, Junbao Liu, et al.. (2014). XELIRI compared with FOLFIRI as a second-line treatment in patients with metastatic colorectal cancer. Oncology Letters. 8(4). 1864–1872. 4 indexed citations
19.
Liu, Junbao, et al.. (2014). Gene Microarray Assessment of Multiple Genes and Signal Pathways Involved in Androgen-dependent Prostate Cancer Becoming Androgen Independent. Asian Pacific Journal of Cancer Prevention. 15(22). 9791–9795. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yueling Jin Breakdown of academic impact, for papers by Shufang Liang Breakdown of academic impact, for papers by Eman Khairy Breakdown of academic impact, for papers by Yiman Liu Breakdown of academic impact, for papers by Tong Xu Breakdown of academic impact, for papers by Małgorzata Guz
Rankless by CCL
2026